Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group

European Journal of Clinical Pharmacology
K J Belton

Abstract

This survey was conducted to assess the attitudes of medical practitioners in the European Union regarding their national spontaneous reporting scheme, to identify reasons for under-reporting and to determine what steps might be effective in increasing reporting rates. National spontaneous reporting schemes rely on health care professionals reporting individual cases of suspected ADRs to a central or regional agency. National schemes, however, vary considerably and reporting rates and patterns differ between member states. Accumulating evidence suggests that doctors' attitudes to national ADR reporting schemes are significant determinants of reporting rates. A self-administered questionnaire and letter of invitation was sent to a random sample of approximately 1% of medical practitioners in each of nine EU member states (Denmark, France, Ireland, Italy, the Netherlands, Portugal, Spain, Sweden and the UK). One month later, a reminder letter and a second copy of the questionnaire was sent to the non-responders (except Denmark and Italy). Response rates, and the percentage of responders who stated that they had reported previously an ADR, varied substantially between countries. Issues that appeared to discourage reporting include...Continue Reading

Citations

Jan 18, 2006·European Journal of Clinical Pharmacology·Emmanuelle GuittonFrench Network of Pharmacovigilance Centres
Mar 10, 2007·European Journal of Clinical Pharmacology·Susanna M WallerstedtLars Ny
Jan 8, 2009·European Journal of Clinical Pharmacology·Marie-Louise JohanssonSusanna M Wallerstedt
Nov 11, 2010·Zeitschrift für Rheumatologie·L GäwertA Strangfeld
Apr 9, 2008·Pharmacy World & Science : PWS·Jean-Marc KrähenbühlOlivier Bugnon
Jan 1, 2009·Pharmacy World & Science : PWS·Ghazal VessalMehri Mollai
Mar 26, 2010·Pharmacy World & Science : PWS·Kang-Nee TingClaire Anderson
Oct 24, 2002·Journal of Clinical Epidemiology·J HasfordB Müller-Oerlinghausen
May 26, 2011·BMC Clinical Pharmacology·Stéphanie BerthetMaryse Lapeyre-Mestre
Aug 13, 2009·BMC Clinical Pharmacology·Kazeem A Oshikoya, Jacob O Awobusuyi
Mar 19, 2013·BMC Pharmacology & Toxicology·K C SantoshI Ralph Edwards
Aug 11, 2011·American Journal of Pharmaceutical Education·Ramadan Mohamed ElkalmiMuhammad Abdul Hadi
Jul 27, 2010·European Journal of Clinical Pharmacology·Florence van HunselKees van Grootheest
Aug 10, 2006·European Journal of Clinical Pharmacology·Manfred HaubenVaishali K Patadia
Jan 15, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kerry Wilbur
Apr 7, 2010·Expert Opinion on Drug Safety·Regis Fuzier, Maryse Lapeyre-Mestre
Feb 26, 2016·Indian Journal of Cancer·Kirandeep KaurSandeep Kaushal
Jan 31, 2016·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Allison Salk, Eli D Ehrenpreis
Jan 29, 2011·Research in Social & Administrative Pharmacy : RSAP·Paul GavazaMary Steinhardt
Oct 16, 2004·Journal of Evaluation in Clinical Practice·Maria T HerdeiroAdolfo Figueiras
Jul 29, 2015·International Journal of Clinical Pharmacy·Thamir M AlshammariHisham S Aljadhey
May 20, 2003·Community Dentistry and Oral Epidemiology·Gunvor Bentung LygreLars Björkman
Dec 12, 2007·British Journal of Clinical Pharmacology·Karin WesterStaffan Hägg
Oct 13, 2011·British Journal of Clinical Pharmacology·Daniel B HawcuttMunir Pirmohamed
Feb 22, 2011·British Journal of Clinical Pharmacology·Paul GavazaMary Steinhardt
Sep 2, 2005·Drug and Alcohol Dependence·Kenneth M Dürsteler-MacFarlandJürgen Rehm
May 26, 2015·European Journal of Clinical Pharmacology·Cristiano MatosJoão Joaquim
Apr 3, 2015·International Journal of Clinical Pharmacy·Jun LiuYu Fang
Sep 10, 2013·Health Policy·Paolo PellegrinoSonia Radice
Oct 1, 2013·Medical Oncology·Pascale Olivier-AbbalFrench Association of Regional Pharmacovigilance Centers
Jun 23, 2016·Journal of Basic and Clinical Pharmacy·Mohamed M M Abdel-Latif
May 15, 2015·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Mohamed M M Abdel-Latif, Basel A Abdel-Wahab
Oct 23, 2014·Revista da Escola de Enfermagem da U S P·Fabiana Rossi VaralloPatricia de Carvalho Mastroianni
Jan 11, 2017·Pharmacoepidemiology and Drug Safety·Lennart HolmKerstin Jorsäter Blomgren
Apr 11, 2018·European Journal of Clinical Pharmacology·Xinling LiJielai Xia
Jun 28, 2011·Pharmacoepidemiology and Drug Safety·Francisca González-RubioAlexandra Prados-Torres
Mar 20, 2014·Pharmacoepidemiology and Drug Safety·Maria-Genalin AngeloFelix Arellano
Mar 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroJ J Gestal-Otero

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Related Papers

European Journal of Clinical Pharmacology
M BäckströmT Nordkvist-Olsson
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Suparna ChatterjeeSouvik Ghosh
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
D Sweis, I C Wong
© 2021 Meta ULC. All rights reserved